Ensign Peak Advisors’s GeneDx Holdings WGS Stock Holding History

Ensign Peak Advisors’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$106K	Sell	1,550 -39,721	-96%	-$2.26M	﹤0.01%	1599
2026 Q1	$2.65M	Sell	41,271 -31,736	-43%	-$2.89M	﹤0.01%	654
2025 Q4	$9.5M	Sell	73,007 -5,974	-8%	-$820K	0.02%	419
2025 Q3	$8.51M	Buy	78,981 +21,739	+38%	+$2.37M	0.01%	484
2025 Q2	$5.28M	Buy	57,242 +55,742	+3,716%	+$4.38M	0.01%	628
2025 Q1	$133K	Sell	1,500 -25,400	-94%	-$2.2M	﹤0.01%	1681
2024 Q4	$2.07M	Buy	+26,900	New	+$1.88M	﹤0.01%	925
2022 Q2	–	Sell	-1,750	Closed	-$177K	–	2206
2022 Q1	$177K	Buy	1,750 +1,035	+145%	+$115K	﹤0.01%	1910
2021 Q4	$105K	Buy	+715	New	+$160K	﹤0.01%	2052

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Ensign Peak Advisors's WGS Position: Q2 2026 in Review

Ensign Peak Advisors reduced its GeneDx Holdings (WGS) stake by 96% in Q2 2026, selling an estimated $2.26M and leaving 1,550 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #1599.

Ensign Peak Advisors first reported a position in WGS in Q4 2021 and has held it in 9 quarters since. The position peaked at $9.5M in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Ensign Peak Advisors held 1,550 shares of GeneDx Holdings worth $106K as of Q2 2026.
Ensign Peak Advisors sold 39,721 GeneDx Holdings shares in Q2 2026, an estimated $2.26M.
GeneDx Holdings made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1599 holding.
Ensign Peak Advisors first reported a position in GeneDx Holdings in Q4 2021 and has held it in 9 quarters since.
Ensign Peak Advisors's GeneDx Holdings position peaked at $9.5M in Q4 2025.
223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.